The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. It explores vaccine intentions, information gaps, vaccine brand preferences, and tests a variety of potential incentives, messages, and pieces of information that might be used to increase vaccination uptake.
This Vaccine Monitor report finds little change since June in the share of adults who either received a COVID-19 vaccine or say they will as soon as they can. A quarter of unvaccinated adults say they likely will get a shot by the end of the year. Unvaccinated adults are much less worried than vaccinated ones about the Delta variant.
Worries about Long-Term and Serious Side Effects are Parents’ Top Concern; Hispanic and Black Parents Are More Likely than White Parents to Cite Access and Cost Issues As schools around the country prepare to reopen, a majority of parents of school-age children say they do not want their children’s schools to require students to get a COVID-19 vaccine in order to attend in person classes, the latest KFF Covid-19 Vaccine Monitor report finds. This includes…
Our latest Vaccine Monitor survey finds that half of the public has heard either “a lot” or “some” about the newly-available bivalent COVID-19 boosters, and a third (32%) say they’ve already gotten it or intend to do so “as soon as possible.” It also updates parents’ vaccine intentions for their children, including those under 5.
The latest KFF/CNN partnership survey examines growing concerns regarding mental health in America, particularly at a time of economic uncertainty and the fallout of the COVID-19 pandemic. This report looks at how mental health impacts U.S. adults, including younger adults, LGBT adults, Hispanic adults, and the uninsured, while also bringing awareness to the new 988 crisis hotline.
This report shows an increasing share of the public are frustrated about the status of COVID-19 vaccinations in the U.S.. The share of fully vaccinated adults who report receiving a booster dose has more than doubled in the last month, though vaccine uptake overall is little changed. The poll also explores attitudes towards federal mandates on workplace vaccinations and the pandemic's toll on different groups.
About half of adults are interested in taking prescription weight loss drugs. though interest drops when presented with obstacles or drawbacks. Many adults struggle with affording prescription drugs and say there should be more price regulation. Few are aware of provisions in the 2023 Inflation Reduction Act aimed at lowering the drug price for Medicare beneficiaries
This report examines the exposure to, and belief in, health misinformation among people living in rural communities, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among Hispanic Americans toward the coronavirus and a generational gap in willingness to get a potential vaccine.
A new analysis of KFF COVID-19 Vaccine Monitor survey data finds that residents of rural America stand out as one of the groups most hesitant to get a COVID-19 vaccine and that their views about the pandemic could pose significant challenges for the nation’s mass vaccination effort. About a third (35%) of people living in rural areas say they probably or definitely would not get a COVID-19 vaccine that had been deemed safe and effective…
© 2026 KFF
